Daylife Select
A point & click tool to create dynamic content portals. Learn More »
Editor's Picks
There is no pinned content in this Editor's Picks module.
Click here to learn more about content pinning.
-
Abbott Laboratories gets a one-two safety punch today. Full Article at FiercePharma
-
US Group Public Citizen Asks FDA To Ban Abbott Laboratories (ABT) Diet Drug 12/4/2009 WASHINGTON, Dec 3 (Reuters) - Abbott Laboratories Inc's (ABT.N) weight-loss drug Meridia should be banned immediately because of heart-... Full Article at Biospace
-
A woman enters the headquarters of Belgian drugs, chemicals and plastics maker Solvay in Brussels, September 28, 2009. View Photo »
-
The campaign is inviting the companies, which include Abbott Laboratories, GlaxoSmithKline, and Pfizer, to place the patents for a list of HIV drugs into a patent pool recently set up by Unitaid, an international agency that partners with organisations including the World Health Organization and UNAIDS ...
SOURCE: Medical News Today -
Today Sue Sutter The US consumer watchdog group Public Citizen has once again petitioned the FDA to immediately ban Abbott Laboratories' weight-loss drug Meridia (sibutramine) owing to cardiovascular safety concerns. Full Article at Scrip News
-
From Associated Press (December 3, 2009) WASHINGTON--A consumer advocacy group is petitioning the government to ban the weight loss pill Meridia because a recent study suggests it increases risk of heart attack, stroke and death. Full Article at Drugs.com
-
Consumer safety group seeks FDA ban of weight loss pill Meridia, citing heart attack risks
Chicago Tribune
WASHINGTON (AP) — A consumer advocacy group is petitioning the government to ban the weight loss pill Meridia because a recent study suggests it increases risk of heart attack, stroke and death. Full Article at Chicago Tribune
-
A view of the logo of Belgian drugs, chemicals and plastics maker Solvay in Brussels, September 28, 2009. View Photo »
-
Genetic biomarkers are at the heart of the new prostate cancer tests we have licensed to Quest Diagnostics and Abbott Laboratories. Combined with our sophisticated analysis tools for identifying positive results from massive amounts of previously unusable clinical data, biomarkers like those patented by...
SOURCE: Freshnews.com -
-
* Abbott says drug is safe when used as directed WASHINGTON (Reuters) - Abbott Laboratories Inc's weight-loss drug Meridia should be banned immediately because of heart-related risks, a consumer group said on Thursday in a petition to U.S. Full Article at Reuters Health: eLine
-
WASHINGTON (AP) — A consumer advocacy group is petitioning the government to ban the weight loss pill Meridia because a recent study suggests it increases risk of heart attack, stroke and death. Full Article at Chicago Tribune
About Abbott Laboratories
Wikipedia
There are no results for this module. Edit this module to change the search term used to query Wikipedia
Related Photos
prev
next
-
Reuters Pictures
A woman enters the headquarters of Belgian drugs, chemicals and plastics maker Solvay in Brussels, September 28, 2009. Solvay said on Monday it would sell its drugs unit to U.S. partner Abbott Laboratories for 4.5 billion euros ($6.6 billion) in cash and reinvest in chemicals and plastics.
View Photo » -
Reuters Pictures
A view of the logo of Belgian drugs, chemicals and plastics maker Solvay in Brussels, September 28, 2009. Solvay said on Monday it would sell its drugs unit to U.S. partner Abbott Laboratories for 4.5 billion euros ($6.6 billion) in cash and reinvest in chemicals and plastics.
View Photo » -
Reuters Pictures
Belgium's Christian Jourquin, chief executive officer of Belgian drugs, chemicals and plastics maker Solvay, holds a news conference in Brussels, September 28, 2009.
View Photo » -
Reuters Pictures
Christian Jourquin, chief executive officer of Belgian drugs, chemicals and plastics maker Solvay, holds a news conference in Brussels, September 28, 2009.
View Photo » -
Reuters Pictures
Christian Jourquin, chief executive officer of Belgian drugs, chemicals and plastics maker Solvay, holds a news conference in Brussels, September 28, 2009.
View Photo » -
Reuters Pictures
Christian Jourquin, chief executive officer of Belgian drugs, chemicals and plastics maker Solvay, holds a news conference in Brussels, September 28, 2009.
View Photo » -
AP Photo
FILE - In this July 13, 2005 file photo provided by Abbott Laboratories, the North Chicago-based company's rheumatoid arthritis therapy Humira, is shown.
View Photo » -
AP Photo
FILE - In this July 13, 2005 file photo provided by Abbott Laboratories, the North Chicago-based company's rheumatoid arthritis therapy Humira, is shown.
View Photo » -
AP Photo
AIDS Healthcare Foundation advocates, joined by Chicago-area medical student activists and the Chicago Women's AIDS Project, protested today outside the Lake Forest, IL home of Abbott Laboratories' CEO Miles D. White over the company's AIDS drug prices in Mexico and Colombia.
View Photo »
Reuters Pictures
A view of the logo of Belgian drugs, chemicals and plastics maker Solvay in Brussels, September 28, 2009. Solvay said on Monday it would sell its drugs unit to U.S. partner Abbott Laboratories for 4.5 billion euros ($6.6 billion) in cash and reinvest in chemicals and plastics.
View Photo »Related Topics
Related Videos
Related Conversations
There are no results for this module. Edit the module to change the search term used to query Twitter.